|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net of allowance of $566 and $85, respectively | |||||||||||||
| Prepaid expenses | |||||||||||||
| Other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property and equipment, net of accumulated depreciation of $5,474 and $4,782, respectively | |||||||||||||
| Goodwill | |||||||||||||
| Intangible assets, net of accumulated amortization of $17,425 and $16,798, respectively | |||||||||||||
| Deferred tax assets | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Shareholders' Deficit | |||||||||||||
| Current liabilities: | |||||||||||||
| Debt | |||||||||||||
| Accounts payable | |||||||||||||
| Deferred revenue | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term debt, net of current portion | |||||||||||||
| Deferred tax liabilities | |||||||||||||
| Other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Common Stock, Shares Authorized | |||||||||||||
| Common stock, outstanding (in shares) | |||||||||||||
| Common stock, issued (in shares) | |||||||||||||
| Common stock, nominal value (in Euro per share) | |||||||||||||
| Treasury stock, shares (in shares) | |||||||||||||
| Shareholders' Deficit: | |||||||||||||
| Common stock, €1.00 nominal value; 3,992,078 shares authorized; 2,661,386 shares issued; 2,625,476 and 2,623,820 shares outstanding as of June 30, 2023 and December 31, 2022 | |||||||||||||
| Treasury stock, at €1.00 nominal value; 43,989 shares as of June 30, 2022 and December 31, 2021 | |||||||||||||
| Treasury stock, at €1.00 nominal value; 35,910 shares as of June 30, 2023 and 37,566 shares as of December 31, 2022 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Accumulated other comprehensive income | |||||||||||||
| Total shareholders' deficit | |||||||||||||
| Total liabilities and shareholders' deficit | |||||||||||||
Loading...